In the complex landscape of pharmaceutical manufacturing, the quality and purity of intermediate compounds are paramount. For targeted cancer therapies like Erlotinib, a potent tyrosine kinase inhibitor, the reliability of its precursor molecules cannot be overstated. One such critical intermediate is 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone, identified by CAS Number 179688-29-0. This compound is not merely a chemical entity; it is a foundational component that directly impacts the efficacy and safety of the final drug product. Understanding its properties and sourcing it from a reputable manufacturer is a cornerstone for any pharmaceutical company involved in Erlotinib production.

The chemical structure of 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone, with its distinct quinazolinone core and methoxyethoxy side chains, lends itself to the specific biochemical interactions required for Erlotinib's function. Erlotinib, marketed under brand names like Tarceva, targets the epidermal growth factor receptor (EGFR), a key driver in certain types of cancer, including non-small cell lung cancer and pancreatic cancer. As a supplier of this vital intermediate, NINGBO INNO PHARMCHEM CO.,LTD. understands the stringent requirements for pharmaceutical-grade materials. Our commitment is to provide 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone with exceptional purity, typically exceeding 99.0%, ensuring that manufacturers can confidently integrate it into their synthesis processes.

The physical characteristics of this intermediate are also noteworthy. It typically presents as a white solid, with a melting point range of 185-189°C. These properties facilitate handling and processing in standard chemical synthesis environments. The reliability of these specifications, combined with a consistent supply chain, makes sourcing from a trusted manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. a strategic advantage. We are dedicated to supporting the pharmaceutical industry by providing the essential building blocks that drive therapeutic innovation. By focusing on the precise synthesis and quality control of intermediates like 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone, we contribute to the availability of life-saving medications.

For pharmaceutical companies looking to buy 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone, prioritizing a supplier with a proven track record in pharmaceutical intermediate manufacturing is crucial. The price and availability can fluctuate, but the assurance of quality and compliance remains constant. NINGBO INNO PHARMCHEM CO.,LTD. stands as a reliable partner, offering this key intermediate to facilitate the production of Erlotinib and support advancements in cancer treatment. Engaging with a knowledgeable manufacturer ensures that your supply chain is robust and that the quality of your final API is never compromised.